Aligos Therapeutics Inc (ALGS)
0.82
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
0.82
0.00 (0.00%)
After-Hours: 20:00
Aligos Therapeutics Free Cash Flow: -79.02M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -79.02M |
| September 30, 2023 | -73.22M |
| June 30, 2023 | -70.02M |
| March 31, 2023 | -81.78M |
| December 31, 2022 | -80.33M |
| September 30, 2022 | -101.27M |
| June 30, 2022 | -109.60M |
| Date | Value |
|---|---|
| March 31, 2022 | -107.40M |
| December 31, 2021 | -116.55M |
| September 30, 2021 | -98.48M |
| June 30, 2021 | -89.93M |
| March 31, 2021 | -85.02M |
| December 31, 2020 | -76.33M |
Free Cash Flow Range, Past 5 Years
-116.55M
Minimum
Dec 2021
-70.02M
Maximum
Jun 2023
-89.92M
Average
-85.02M
Median
Mar 2021
Free Cash Flow Benchmarks
| Mirum Pharmaceuticals Inc | -91.05M |
| CEL-SCI Corp | -23.45M |
| AIM ImmunoTech Inc | -21.85M |
| IGC Pharma Inc | -6.55M |
| NovaBay Pharmaceuticals Inc | -4.15M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -22.66M |
| Cash from Investing (Quarterly) | -0.007M |
| Cash from Financing (Quarterly) | 87.94M |
| Free Cash Flow Per Share (Quarterly) | -0.3018 |
| Free Cash Flow to Equity (Quarterly) | -22.66M |
| Free Cash Flow to Firm (Quarterly) | -21.20M |
| Free Cash Flow Yield | -188.3% |